BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9674047)

  • 1. [The concept of "hemorrhage-ischemia" and its therapeutic applications].
    Tellería-Díaz A; García OD; Sánchez-Chávez JJ
    Rev Neurol; 1998 Jul; 27(155):160-1. PubMed ID: 9674047
    [No Abstract]   [Full Text] [Related]  

  • 2. Artificial oxygen carriers and the cerebral circulation.
    Lenz C; Waschke F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Nov; 36 Suppl 2():S110-3. PubMed ID: 11753713
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?
    Zemke D; Farooq MU; Mohammed Yahia A; Majid A
    Vasc Med; 2007 Aug; 12(3):243-9. PubMed ID: 17848485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium antagonists in the therapy of cerebrovascular diseases].
    Cosmi F
    Clin Ter; 1985 Mar; 112(5):465-8. PubMed ID: 4017471
    [No Abstract]   [Full Text] [Related]  

  • 5. Cilostazol in Cerebral Ischemia and Subarachnoid Hemorrhage: A Promising Agent as Prevention.
    Aspide R; Castioni CA
    Neurocrit Care; 2023 Feb; 38(1):7-8. PubMed ID: 36450973
    [No Abstract]   [Full Text] [Related]  

  • 6. 17-beta estradiol can reduce secondary ischemic damage and mortality of subarachnoid hemorrhage.
    Yang SH; He Z; Wu SS; He YJ; Cutright J; Millard WJ; Day AL; Simpkins JW
    J Cereb Blood Flow Metab; 2001 Feb; 21(2):174-81. PubMed ID: 11176283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus-associated vasculopathy with CNS compartmentalization of HIV-1.
    Guedes BF; Gomes HR; Lucato LT; Puglia P; Nitrini R; Castro LH
    J Neurovirol; 2015 Feb; 21(1):101-4. PubMed ID: 25537635
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
    Wurm G; Tomancok B; Nussbaumer K; Adelwöhrer C; Holl K
    Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extract of Ginkgo biloba promotes the expression of VEGF following subarachnoid hemorrhage in rats.
    Sun BL; Hu DM; Yuan H; Ye WJ; Wang XC; Xia ZL; Zhang SM; Wang LX
    Int J Neurosci; 2009; 119(7):995-1005. PubMed ID: 19466634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study.
    Stein SC; Browne KD; Chen XH; Smith DH; Graham DI
    Neurosurgery; 2006 Oct; 59(4):781-7; discussion 787-8. PubMed ID: 16915120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment.
    van den Bergh WM; Albrecht KW; Berkelbach van der Sprenkel JW; Rinkel GJ
    Acta Neurochir (Wien); 2003 Mar; 145(3):195-9; discussion 199. PubMed ID: 12632115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best evidence topic reports. Does nimodipine reduce mortality and secondary ischaemic events after subarachnoid haemorrhage?
    Brown G; Carley S
    Emerg Med J; 2004 May; 21(3):333. PubMed ID: 15107373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical care management of subarachnoid hemorrhage and ischemic stroke.
    Seder DB; Mayer SA
    Clin Chest Med; 2009 Mar; 30(1):103-22, viii-ix. PubMed ID: 19186283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of erythropoietin.
    Gu YL; Zhao ZX
    J Neurosurg; 2014 Jan; 120(1):293-4. PubMed ID: 24180572
    [No Abstract]   [Full Text] [Related]  

  • 15. Subarachnoid hemorrhage: a multiple-organ system disease.
    Diringer MN
    Crit Care Med; 2003 Jun; 31(6):1884-5. PubMed ID: 12794446
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis of APOE genotype and subarachnoid hemorrhage: clinical outcome and delayed ischemia.
    Lanterna LA; Ruigrok Y; Alexander S; Tang J; Biroli F; Dunn LT; Poon WS
    Neurology; 2007 Aug; 69(8):766-75. PubMed ID: 17709709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of subarachnoid hemorrhage and its complications].
    Porubec V; Bartko D
    Cesk Neurol Neurochir; 1988 Jan; 51(1):9-17. PubMed ID: 3359524
    [No Abstract]   [Full Text] [Related]  

  • 19. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978-984, May, 2003.
    Egge A; Waterloo K; Sjøholm H; Solberg T; Ingebrigtsen T; Romner B
    J Neurosurg; 2004 Feb; 100(2):359-60; author reply 360. PubMed ID: 15086250
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    van den Bergh WM; Mees SM; Rinkel GJ
    Neurosurgery; 2006 Nov; 59(5):E1152; author reply E1152. PubMed ID: 17143226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.